RESEARCH PLATFORM ACTIVE

Where AI Meets Biology to Save Lives

YutaniAI compresses decades of drug discovery into months. Our AI platform designs novel therapeutics, predicts protein structures, and optimizes clinical trials -- from target identification to FDA approval.

Compounds Screened

Active Drug Programs

Faster Discovery

LIVE PROTEIN FOLDING SIMULATION

Building Beyond the Incumbents

GENENTECH MODERNA BIONTECH ATOMWISE RECURSION WEYLAND-YUTANI

Platform Capabilities

Six Pillars of Next-Generation Biotechnology

Every capability powered by proprietary AI models trained on billions of molecular interactions, protein structures, and clinical outcomes.

AI Drug Discovery

Deep learning models screen billions of molecular candidates in hours, not years. Predict binding affinity, toxicity, and ADMET properties with 94% accuracy before synthesis.

2.4M+ compounds screened

mRNA Sequence Design

Generate optimized mRNA sequences for any target protein. Codon optimization, UTR engineering, and lipid nanoparticle formulation -- all guided by transformer models.

next-gen therapeutics

Protein Engineering

Predict 3D protein structures from sequence alone. Design novel enzymes, antibodies, and receptor proteins with atomic-level precision using diffusion-based generative models.

AlphaFold-class accuracy

Clinical Trial Optimization

AI-driven patient stratification, adaptive trial design, and real-time endpoint analysis. Reduce trial duration by 40% while improving statistical power and safety monitoring.

40% faster trials

Genomic Analysis

Whole-genome sequencing analysis at scale. Identify disease-linked variants, predict gene expression, and map regulatory networks across populations with single-nucleotide resolution.

single-nucleotide precision

Precision Medicine

Match patients with optimal therapies using multi-omic profiling. Integrate genomics, proteomics, metabolomics, and clinical data for truly personalized treatment protocols.

multi-omic integration

Drug Pipeline

Therapeutics in Development

Our AI-designed drug candidates progressing through discovery, preclinical, and clinical phases across oncology, immunology, and rare diseases.

Discovery

Target identification & lead optimization

YUT-001 (NSCLC) YUT-002 (AML) YUT-005 (NASH)

Preclinical

In-vitro / in-vivo validation & IND filing

YUT-003 (TNBC) YUT-007 (SMA)

III

Phase I / II

Safety, dosing & preliminary efficacy

YUT-004 (GBM) YUT-006 (RA)

Phase III / Filing

Pivotal trials & regulatory submission

2027 target

Research Metrics

Numbers That Matter

Quantifiable progress across every dimension of drug discovery and development.

0M+

Compounds Screened

+340K this quarter

Patents Filed

12 granted, 11 pending

Active Clinical Trials

across 4 therapeutic areas

Prediction Accuracy

binding affinity models

Genomic Intelligence

Real-Time Mutation Detection at Single-Nucleotide Resolution

Our genomic analysis engine processes whole-genome sequences in minutes, identifying disease-linked variants, structural variants, and regulatory mutations with clinical-grade accuracy.

Pathogenic variant identification across 6,000+ known disease genes
Pharmacogenomic profiling for drug response prediction
Somatic mutation calling for tumor characterization
Structural variant detection (CNVs, translocations, inversions)
CRISPR guide RNA design with off-target prediction

SEQUENCE ANALYZER v3.2 chr17:7,674,220-7,674,290 | TP53 exon 7

Adenine Thymine Guanine Cytosine Mutation

Pricing

Plans for Every Stage of Research

From academic research labs to global pharmaceutical enterprises. Scale computational power as your programs advance.

Academic

Free / forever

For university researchers and non-profit institutions advancing open science.

Protein structure prediction (100/mo)
Molecular docking simulations
Genomic variant analysis
Community model access
Public dataset integrations
Academic publication support

Biotech

$4,900 / mo

For biotech startups and mid-size companies with active drug programs.

Unlimited protein predictions
AI drug candidate generation
mRNA sequence optimization
Clinical trial design tools
Priority GPU compute clusters
Dedicated success engineer
GxP-compliant audit trails
API access (100K calls/mo)

Pharma Enterprise

Custom

For global pharmaceutical companies needing dedicated infrastructure and white-glove support.

Everything in Biotech
On-premise deployment option
Custom model training
Regulatory submission support
Multi-site license management
24/7 dedicated support team
IP ownership guarantees
FDA 21 CFR Part 11 compliance

Accelerate Your Research

Join leading institutions already using YutaniAI to transform drug discovery. Early access grants priority GPU allocation and dedicated onboarding.

Join 340+ research institutions on the waitlist. No credit card required.